Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,106 Gastrointestinal
clinical trials

Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hope Research Development
mi
from
Whittier, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Brighan and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
TriHealth Digestive Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Fargo Gastroenterology Clinic, PC
mi
from
Fargo, ND
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Hazard
mi
from
Hazard, KY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC
mi
from
Houma, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Fatty Liver Clinical Trial
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Lenus Research & Medical Group
mi
from
Sweetwater, FL
Click here to add this to my saved trials
Appendicitis Clinical Trial
Pediatric Appendicitis Risk Calculator (pARC) in Children With Appendix Ultrasounds
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Val Hansen
mi
from
Bountiful, UT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Monash Health, Monash Medical Centre
mi
from
Clayton,
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Research, LLC
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Scott & White Research Institute
mi
from
Temple, TX
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Center for Advanced GI
mi
from
Maitland, FL
Click here to add this to my saved trials
Dysphagia Clinical Trial
Motor Imagery Exercise and Tongue Strength
Status: Enrolling
Updated: 12/31/1969
Sarah Hegyi Szynkiewicz, PhD, CCC-SLP
mi
from
Sarasota, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling, Phase III
Updated: 12/31/1969
ClinRX Research LLC
mi
from
Carrollton, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease & Surgery Institute
mi
from
Cleveland, OH
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling, Phase III
Updated: 12/31/1969
Aa Mrc Llc
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hermann Southeast Medical Plaza 1
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling, Phase III
Updated: 12/31/1969
Sante Clinical Research
mi
from
Kerrville, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Center of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology, Neurology, Psychiatry / Psychology Clinical Trial
The Gut-Brain Study
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's Hospital Los Angles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Medical Center-McAuley Plaza
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Redwood City, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Burlington, VT
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kindred Medical Institute for Clinical Trials
mi
from
Long Beach, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Pinnacle Clinical Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Phoenician Centers for Research and Innovation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Chronic Pressure Ulcers Clinical Trial
PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.
Status: Enrolling
Updated: 12/31/1969
NYU Winthrop Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Liver Cirrhosis Clinical Trial
Assessing Cirrhosis Quality of Care While Accounting for Cost
Status: Enrolling, Phase
Updated: 12/31/1969
New York Presbyterian Hospital / Weill Cornell Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Collection of Gastrointestinal Malignant and Non-malignant Human Samples
Status: Enrolling, Phase
Updated: 12/31/1969
The University of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Citrus Valley Health Partners
mi
from
Covina, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Medical Center - Grafton
mi
from
Grafton, WI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Biopharma Informatic Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
GI Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lemah Creek Clinical Research
mi
from
Melrose Park, IL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research - Salt Lake City
mi
from
Ogden, UT
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Combined Research Orlando Phase I-IV LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Pensacola, PA
mi
from
Pensacola, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research - Youngstown
mi
from
Poland, OH
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tyler Research Institute, LLC
mi
from
Tyler, TX
Click here to add this to my saved trials
Primary Sclerosing Cholangitis Clinical Trial
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor Scott & White Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Tube Feeding Clinical Trial
Incidence of Diarrhea Using High and Low Osmolality Enteral Tube Feeding in Critically Ill Surgical Patients
Status: Enrolling
Updated: 12/31/1969
University of Utah Health
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advantage Clinical Trials
mi
from
Bronx, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
TrialSpark
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advance Clinical Research - Dayton Internal Medicine
mi
from
Dayton, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolina Research Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC
mi
from
Houma, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
GI Specialists of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Michigan University Homer Stryker MD School of Medicine
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid America Gastrointestinal Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Skemp Healthcare
mi
from
La Crosse, WI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Clinical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Alliance Medical Research LLC
mi
from
Lighthouse Point, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Nova Clinical Research Center LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Omega Research Maitland
mi
from
Orlando, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Revive Research Institute
mi
from
Southfield, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Gastroenterology
mi
from
Union City, TN
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Harvard Medical School - Beth Israel Deaconess Medical Center (BIDMC) - The Center for Vascular Biol
mi
from
Boston, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Reseach of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley View Internal Medicine
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Floridian Clinical Research LLC
mi
from
Hialeah, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Om Research
mi
from
Lancaster, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
ABS Health, LLC
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Nola Research Works
mi
from
New Orleans, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Medical Center - New Center One
mi
from
Novi, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Circuit Clinical
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Accurate Clinical Research Inc
mi
from
Pasadena, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
DHAT Research Institute
mi
from
Richardson, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Sutter Medical Group
mi
from
Roseville, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatologist Specialists of Spokane
mi
from
Spokane, WA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Penn State University Milton S Hershey Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Gastroenterology institute
mi
from
Suffolk, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clin. Rsrch Inst. of Michigan
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Qway Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Southtowns Gastroenterology, PLLC
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
ClinRX Research Joseph INC
mi
from
Carrollton, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Tandem Clinical Research
mi
from
Marrero, LA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Professional Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Garden City
mi
from
Garden City, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph London
mi
from
London, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolinas HealthCare System Digestive Health
mi
from
Charlotte, NC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center - University Cardiovascular Surgeons
mi
from
Chicago, IL
Click here to add this to my saved trials
1 … 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 … 101